Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Annalisa Paviglianiti: Real-World Outcomes of Maribavir for CMV After Hematopoietic Cell Transplantation
Apr 20, 2026, 14:46

Annalisa Paviglianiti: Real-World Outcomes of Maribavir for CMV After Hematopoietic Cell Transplantation

Annalisa Paviglianiti, Hematologist at Hospital de la Santa Creu i Sant Pau, shared a post on LinkedIn about a recent article she and her colleges co-authored, published in The Lancet Infectious Diseases, adding:

“Excited to share that our article on maribavir is now published online!

This European cohort is the first to report such a large number of patients treated with MBV for CMV infection in the HCT setting.

Encouraging response rates, along with a favorable safety profile.

Promising outcomes, even beyond current EMA-approved indications.

Curious to hear how others are using MBV in practice?”

Title: Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study

Authors: Annalisa Paviglianiti, Per Ljungman, Rafael de la Camara, Gloria Tridello, Juana Schwartz, Nina Knelange, Arancha Bermudez Rodriguez, María Suárez-Lledó, Johan Maertens, Maria Stamouli, Francis Ayuk, Candela Ceballos, Maria Huguet, Felipe Peña Muñoz, Pablo Granados, Alienor Xhaard, Jurgen Kuball, Chiara Nozzoli, Jan Styczynski, Dina Averbuch, Francesca Kinsella, Alejandro Avendano, Hakan Ozodogu, Jose Rifon Roca, Nicole Morrow, Marta Stanzani, Marina Popova, Jerome Cornillon, Tsila Zuckerman, Massimo Martino, Johannes Clausen

https://www.sciencedirect.com/science/article/pii/S1473309926001441

Stay updated on all scientific advances with Hemostasis Today.